You are currently viewing a new version of our website. To view the old version click .

Pharmaceuticals, Volume 16, Issue 6

June 2023 - 131 articles

Cover Story: Over the past decades, peptides and proteins have been increasingly important in treating various human diseases and conditions. However, the practically impermeable blood–brain barrier (BBB) limits the entry of macromolecular therapeutics into the central nervous system (CNS). Thus, developing effective localized delivery strategies for these therapeutics has gained extensive attention, owing to their ability to circumvent the physiological barrier to directly introduce macromolecules into the CNS to improve therapeutic effects and reduce systemic side effects. This review discusses various local administration and formulation strategies that have shown success in treating CNS diseases using peptide/protein therapeutics. Lastly, it discusses the challenges and future perspectives of these approaches. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (131)

  • Communication
  • Open Access
2 Citations
10,186 Views
10 Pages

Amantadine in Treatment of Dysthymia—The Pilot Case Series Study

  • Marek Krzystanek,
  • Ewa Martyniak,
  • Artur Pałasz,
  • Katarzyna Skałacka,
  • Artur Chwalba and
  • Piotr Wierzbiński

Dysthymia is a common chronic mood disorder in which isolated symptoms of depression persist for at least 2 years. Despite the many medications recommended for the treatment of dysthymia, no recommendations have yet been made for the treatment of pat...

  • Article
  • Open Access
6 Citations
3,315 Views
19 Pages

Riluzole, a Derivative of Benzothiazole as a Potential Anti-Amoebic Agent against Entamoeba histolytica

  • Maritza Velásquez-Torres,
  • José Guadalupe Trujillo-Ferrara,
  • Marycarmen Godínez-Victoria,
  • Rosa Adriana Jarillo-Luna,
  • Víctor Tsutsumi,
  • Virginia Sánchez-Monroy,
  • Araceli Posadas-Mondragón,
  • Roberto Issac Cuevas-Hernández,
  • José Angel Santiago-Cruz and
  • Judith Pacheco-Yépez

Amoebiasis is produced by the parasite Entamoeba histolytica; this disease affects millions of people throughout the world who may suffer from amoebic colitis or amoebic liver abscess. Metronidazole is used to treat this protozoan, but it causes impo...

  • Article
  • Open Access
31 Citations
3,924 Views
21 Pages

Isolation, Purification, and Structural Characterization of Polysaccharides from Codonopsis pilosula and Their Anti-Tumor Bioactivity by Immunomodulation

  • Nan Li,
  • Ying-Xia Xiong,
  • Fan Ye,
  • Bing Jin,
  • Jin-Jia Wu,
  • Miao-Miao Han,
  • Tian Liu,
  • Yi-Kai Fan,
  • Cun-Yu Li and
  • Jiu-Shi Liu
  • + 4 authors

The activity of polysaccharides is usually related to molecular weight. The molecular weight of polysaccharides is critical to their immunological effect in cancer therapy. Herein, the Codonopsis polysaccharides of different molecular weights were is...

  • Article
  • Open Access
7 Citations
4,349 Views
17 Pages

Baricitinib Lipid-Based Nanosystems as a Topical Alternative for Atopic Dermatitis Treatment

  • Núria Garrós,
  • Paola Bustos-Salgados,
  • Òscar Domènech,
  • María José Rodríguez-Lagunas,
  • Negar Beirampour,
  • Roya Mohammadi-Meyabadi,
  • Mireia Mallandrich,
  • Ana C. Calpena and
  • Helena Colom

Atopic dermatitis (AD) is a chronic autoimmune inflammatory skin disorder which causes a significant clinical problem due to its prevalence. The ongoing treatment for AD is aimed at improving the patient’s quality of life. Additionally, glucoco...

  • Review
  • Open Access
21 Citations
4,713 Views
21 Pages

Fungal infections remain a significant concern for human health. The emergence of microbial resistance, the improper use of antimicrobial drugs, and the need for fewer toxic antifungal treatments in immunocompromised patients have sparked substantial...

  • Article
  • Open Access
2 Citations
3,236 Views
18 Pages

Assessment of Physicochemical Parameters and Contaminants in Herbal Dietary Supplements Used in the Treatment of Inflammatory Bowel Disease

  • Daniela Amidžić Klarić,
  • Jelena Kovačić,
  • Mario-Livio Jeličić,
  • Snježana Zubčić,
  • Vladimir Stankov,
  • Marija Gulan Čičak,
  • Boris Bučar,
  • Ilija Klarić and
  • Ana Mornar

Inflammatory bowel disease is a complex disorder characterized by chronic gastrointestinal inflammation. Thus, patients prefer to use herbal dietary supplements containing turmeric, Indian frankincense, green chiretta, and black pepper in an attempt...

  • Review
  • Open Access
352 Citations
69,934 Views
11 Pages

The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies

  • Alexandre Blanco-González,
  • Alfonso Cabezón,
  • Alejandro Seco-González,
  • Daniel Conde-Torres,
  • Paula Antelo-Riveiro,
  • Ángel Piñeiro and
  • Rebeca Garcia-Fandino

Artificial intelligence (AI) has the potential to revolutionize the drug discovery process, offering improved efficiency, accuracy, and speed. However, the successful application of AI is dependent on the availability of high-quality data, the addres...

  • Article
  • Open Access
8 Citations
2,666 Views
19 Pages

Inhibition of TRPA1, Endoplasmic Reticulum Stress, Human Airway Epithelial Cell Damage, and Ectopic MUC5AC Expression by Vasaka (Adhatoda vasica; Malabar Nut) Tea

  • Tosifa A. Memon,
  • Lili Sun,
  • Marysol Almestica-Roberts,
  • Cassandra E. Deering-Rice,
  • Philip J. Moos and
  • Christopher A. Reilly

This study tested whether a medicinal plant, Vasaka, typically consumed as a tea to treat respiratory malaise, could protect airway epithelial cells (AECs) from wood smoke particle-induced damage and prevent pathological mucus production. Wood/biomas...

  • Review
  • Open Access
4 Citations
2,455 Views
15 Pages

Pharmacogenetic Testing for the Pediatric Gastroenterologist: Actionable Drug–Gene Pairs to Know

  • Tracy Sandritter,
  • Rachel Chevalier,
  • Rebecca Abt and
  • Valentina Shakhnovich

Gastroenterologists represent some of the earlier adopters of precision medicine through pharmacogenetic testing by embracing upfront genotyping for thiopurine S-methyltransferase nucleotide diphosphatase (TPMT) before prescribing 6-mercaptopurine or...

  • Article
  • Open Access
4 Citations
2,554 Views
31 Pages

In the search for innovative approaches to cancer chemotherapy, a chemical library of 49 cyanochalcones, 1a-r, 2a-o, and 3a-p, was designed as dual inhibitors of human farnesyltransferase (FTIs) and tubulin polymerization (MTIs) (FTIs/MTIs), two impo...

of 14

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247Creative Common CC BY license